Tevogen Bio Holdings Inc's Comment on Supply Chain
The company faces challenges in sourcing raw materials due to limited negotiation leverage and recent supply chain disruptions in the biotechnology market. There is a risk that suppliers may not provide required quantities or meet quality specifications, particularly for limited or sole-sourced materials, which could delay manufacturing. The company outsources clinical trials and preclinical studies to third parties, including universities, medical institutions, clinical investigators, contract laboratories, and other entities. These third parties conduct GLP-compliant preclinical studies and GCP-compliant clinical trials; however, the company has limited control over their performance and timing. Any failure by suppliers or third parties could delay the development, regulatory approval, and commercialization of the company's product candidates, adversely affecting its business.
Tevogen Bio Holdings Inc's Comment on Supply Chain
The company faces challenges in sourcing raw materials due to limited negotiation leverage and recent supply chain disruptions in the biotechnology market. There is a risk that suppliers may not provide required quantities or meet quality specifications, particularly for limited or sole-sourced materials, which could delay manufacturing. The company outsources clinical trials and preclinical studies to third parties, including universities, medical institutions, clinical investigators, contract laboratories, and other entities. These third parties conduct GLP-compliant preclinical studies and GCP-compliant clinical trials; however, the company has limited control over their performance and timing. Any failure by suppliers or third parties could delay the development, regulatory approval, and commercialization of the company's product candidates, adversely affecting its business.
Sources:
Tevogen Bio Holdings Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Tevogen Bio Holdings Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
